Landaas & CO Teva Pharmaceutical Industries LTD Transaction History

Landaas & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $21,207 - $25,829	-1,007 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$16.77 - $24.71 $16,887 - $24,882	1,007 New	1,007 $24,000
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $16,796 - $22,224	-1,007 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$11.23 - $19.1 $943 - $1,604	-84 Reduced 7.7%	1,007 $19,000
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $16,812 - $35,097	1,091	1,091 $19,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.